John W. Holaday

Accevolance, Inc. engages in providing clinical research and development services. It operates through the following core service divisions: Full-Service CRO, Patient Recruitment, and Clinical Call Center. The Full-Service CRO division includes protocol development, project management, clinical trial monitoring, data management, Biostatistics, Pharmacovigilance, regulatory affairs, and medical writing. The Patient Recruitment division involves patient recruitment and management. The Clinical Call Center division provides recruitment, retention, and compliance; post approval safety studies; Phase IV studies; surveillance programs; patient-reported outcomes; observational studies; registries; site support services; patient market research; and risk management support. The company was founded by Stephen J. Trevisan in 2005 and is headquartered in Rockville, MD.

Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.

HarVest Bank of Maryland brings a unique business perspective which leverages the skills, experience and knowledge of its Board of Directors and management team. Clients benefit from in-house advisory services designed to help them manage operational, financial and growth needs. HarVest Bank of Maryland is participating in the FDIC's Transaction Account Guarantee Program. Under that program, through June 30, 2010, all noninterest-bearing transaction accounts are fully guaranteed by the FDIC for the entire amount in the account. Coverage under the Transaction Account Guarantee Program is in addition to and separate from the coverage available under the FDIC's general deposit insurance rules.

Math for America is a non-profit organization that aims to improve math education in secondary public schools. The non-profit company is based in New York, NY.

Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom.

Part of Guardian Medical Solutions Ltd., CNSCo, Inc. is an American company that develops biotechnology and biopharmaceutical products. The company is located in the US. The company was founded by John W. Holaday. CNSCo was acquired by Guardian Medical Solutions Ltd. on April 26, 2007.

Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX.

Part of The Health Plan of West Virginia, Inc., DisposeRx, Inc. provides drug diversion, overdoses, accidental poisonings and antibiotic resistance behavior services. The company is based in Sanford, NC. The company was founded in 1966 by John W. Holaday. DisposeRx was acquired by The Health Plan of West Virginia, Inc. on March 18, 2021.

QRxpharma Ltd. (United States) engages in the development and commercialization of biopharmaceutical products. The company is headquartered in Bedminster, NJ.